Medicina de Familia-SEMERGEN最新文献

英文中文

Exantema escarlatiniforme por Arcanobacterium: reporte de un caso y revisión de la literatura 金孢杆菌引起的红斑样皮疹：病例报告和文献综述

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2026-01-01 Epub Date: 2026-01-08 DOI: 10.1016/j.semerg.2025.102655

B. Chao Maseda, M.C. Paredes Suárez, C. Cánovas Seva, Á. Flórez

引用次数: 0

Discrepancias en la percepción de la detección y el correcto manejo de la ERC entre especialidades médicas en España 西班牙各医疗专业对ERC检测和正确管理的看法存在差异

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2026-01-01 Epub Date: 2026-01-08 DOI: 10.1016/j.semerg.2025.102672

A. Izarra , D. Ollero Rodríguez , A. Díez García , N. Fernández Rebollo , J.M. Martinón Martínez , M. García Castillo , A. Andrés Herrero , A. Villarroel Vargas , J.L. Górriz , J. Escalada San Martín , N. Aresté Fosalba , A. Lecube

Objective

Chronic kidney disease (CKD) is a global health problem. In 2022, a consensus document with CKD management recommendations was published in Spain. We aimed to analyze the perception of nephrology, endocrinology and primary care physicians (PCPs) specialist in Spain regarding the adoption of these guidelines.

Materials and methods

Descriptive, national, multicenter study of professionals’ perceptions regarding the adoption of the main recommendations of the consensus document. Differences between specialties were also explored. Perceptions were gathered during 40 meetings held by AstraZeneca in Spain.

Results

Most specialists perceived significant underdiagnosis of CKD. Nephrologists and endocrinologists perceived low adoption of the CKD screening recommendation in PCPs, in contrast to what PCPs reported about their own practice. Regarding referrals to nephrology, 48.5% of nephrologists and 79.3% of endocrinologists and 77.8% of PCPs (referring to their own clinics) perceived high adoption. About 63.8% of nephrologists and 52.8% of PCPs perceived high adoption of the recommendation on effective communication between them. Endocrinologists perceived higher adoption of the recommendation to use a combined therapeutic strategy compared to PC and nephrology.

Conclusions

The study showed low adherence to the recommendations, highlighting the need to encourage full adoption of the guidelines and to improve communication among professionals to optimize CKD diagnosis and treatment.

目的慢性肾脏疾病（CKD）是一个全球性的健康问题。2022年，西班牙发表了CKD管理建议的共识文件。我们的目的是分析西班牙肾脏病学、内分泌学和初级保健医生（pcp）专家对采用这些指南的看法。材料和方法对采纳共识文件主要建议的专业人士看法的描述性、全国性、多中心研究。还探讨了专业之间的差异。阿斯利康在西班牙举行了40次会议，收集了人们的看法。结果大多数专家认为CKD的诊断严重不足。肾病学家和内分泌学家认为，与pcp报告的自己的实践相反，pcp对CKD筛查建议的采纳率较低。关于转诊到肾病科，48.5%的肾病科医生、79.3%的内分泌科医生和77.8%的pcp（转诊到自己的诊所）认为接受度很高。约63.8%的肾病科医生和52.8%的pcp认为他们之间的有效沟通采纳了该建议。内分泌学家认为，与PC和肾脏病学相比，采用联合治疗策略的建议更高。结论：该研究显示对指南的依从性较低，强调了鼓励全面采用指南并改善专业人员之间沟通以优化CKD诊断和治疗的必要性。

{"title":"Discrepancias en la percepción de la detección y el correcto manejo de la ERC entre especialidades médicas en España","authors":"A. Izarra , D. Ollero Rodríguez , A. Díez García , N. Fernández Rebollo , J.M. Martinón Martínez , M. García Castillo , A. Andrés Herrero , A. Villarroel Vargas , J.L. Górriz , J. Escalada San Martín , N. Aresté Fosalba , A. Lecube","doi":"10.1016/j.semerg.2025.102672","DOIUrl":"10.1016/j.semerg.2025.102672","url":null,"abstract":"<div><h3>Objective</h3><div>Chronic kidney disease (CKD) is a global health problem. In 2022, a consensus document with CKD management recommendations was published in Spain. We aimed to analyze the perception of nephrology, endocrinology and primary care physicians (PCPs) specialist in Spain regarding the adoption of these guidelines.</div></div><div><h3>Materials and methods</h3><div>Descriptive, national, multicenter study of professionals’ perceptions regarding the adoption of the main recommendations of the consensus document. Differences between specialties were also explored. Perceptions were gathered during 40 meetings held by AstraZeneca in Spain.</div></div><div><h3>Results</h3><div>Most specialists perceived significant underdiagnosis of CKD. Nephrologists and endocrinologists perceived low adoption of the CKD screening recommendation in PCPs, in contrast to what PCPs reported about their own practice. Regarding referrals to nephrology, 48.5% of nephrologists and 79.3% of endocrinologists and 77.8% of PCPs (referring to their own clinics) perceived high adoption. About 63.8% of nephrologists and 52.8% of PCPs perceived high adoption of the recommendation on effective communication between them. Endocrinologists perceived higher adoption of the recommendation to use a combined therapeutic strategy compared to PC and nephrology.</div></div><div><h3>Conclusions</h3><div>The study showed low adherence to the recommendations, highlighting the need to encourage full adoption of the guidelines and to improve communication among professionals to optimize CKD diagnosis and treatment.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"52 1","pages":"Article 102672"},"PeriodicalIF":0.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Más allá del dolor muscular: un caso de síndrome de Paget-Schroetter en un deportista joven [肌肉疼痛之外：一名年轻运动员的佩吉-施罗德综合征]。

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-12-01 Epub Date: 2025-11-10 DOI: 10.1016/j.semerg.2025.102621

A. Carrero Grande, M.C. Mateo Pascual

引用次数: 0

Infección por Mycobacterium marinum tras exposición a acuarios: revisión de casos publicados y experiencia clínica 【水族箱暴露后海洋分枝杆菌感染：已发表病例和临床经验综述】。

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-12-01 Epub Date: 2025-11-05 DOI: 10.1016/j.semerg.2025.102622

C. Llamas-Segura, M.D. Pegalajar-García, I. Pérez-López, R. Ruiz-Villaverde, L. Linares-González

引用次数: 0

Tratamiento y erradicación de la infección por Helicobacter pylori en Atención Primaria 初级保健中幽门螺杆菌感染的治疗和根除

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-12-01 Epub Date: 2025-11-11 DOI: 10.1016/j.semerg.2025.102642

E. Morales Hernández , J.L. Ballvé Moreno , C. Becerra Monzón , M.L. Rodríguez Ormeño , S. Calero Muñoz , N. Parellada Esquius , Y. Rando Matos

Objective

To describe the therapy used for Helicobacter pylori (HP) infection and obtain the eradication rate in primary care (PC).

Material and methods

Descriptive cross-sectional observational study conducted at the Florida Primary Care Centre in L’Hospitalet de Llobregat (Barcelona). The study population consisted of patients aged 15 years or older with HP infection, and the variables were: active ingredients prescribed and their regimen, evaluation of eradication 28 days after diagnosis, sex, age, and country of origin.

Results

In 2018-2019-2020, 1,023 cases of HP were diagnosed, 65.4% (669) were women, mean age 47.17 years (SD 15.7; range 15-93), 56.9% of Spanish origin and 28.3% from Latin America. Quadruple therapy without bismuth with omeprazole 20 mg (OCAM20) was prescribed in 27.4% of the total, classic triple therapy with omeprazole 20 mg (OCA20) in 15%, and quadruple therapy with a single three-in-one capsule containing metronidazole, tetracycline, and bismuth (MTB) with omeprazole in 14.3%. In 15.9% of cases, no treatment was recorded, and in 9.3% of cases, an incorrect regimen was found. Verification tests were performed in 614 cases. It was found that OCA20 achieved an eradication rate of 82.3%, OCA with 40 mg/12 hours achieved 89.8%, OCAM20 achieved 88.0% and MTB achieved 84.7%, with no statistically significant differences between regimens (p=0.674).

目的：介绍幽门螺杆菌（HP）感染的治疗方法，并了解其在初级保健（PC）中的根除率。材料和方法：在L'Hospitalet de Llobregat（巴塞罗那）的佛罗里达初级保健中心进行的描述性横断面观察研究。研究人群包括年龄在15岁或以上的HP感染患者，变量包括：处方的有效成分及其治疗方案、诊断后28天的根除评估、性别、年龄和原产国。结果：2018-2019-2020年，确诊HP病例1023例，65.4%（669例）为女性，平均年龄47.17岁（SD 15.7；范围15-93），56.9%为西班牙裔，28.3%为拉丁美洲裔。不含铋的奥美拉唑20 mg （OCAM20）四联治疗占总数的27.4%，奥美拉唑20 mg （OCA20）经典三联治疗占15%，甲硝唑、四环素、铋（MTB）三合一胶囊联合奥美拉唑四联治疗占14.3%。在15.9%的病例中，没有治疗记录，在9.3%的病例中，发现了错误的方案。对614例进行了验证试验。结果发现，OCA20根除率为82.3%，OCA 40 mg/12 h根除率为89.8%，OCAM20根除率为88.0%，MTB根除率为84.7%，两组间差异无统计学意义（p=0.674）。

{"title":"Tratamiento y erradicación de la infección por Helicobacter pylori en Atención Primaria","authors":"E. Morales Hernández , J.L. Ballvé Moreno , C. Becerra Monzón , M.L. Rodríguez Ormeño , S. Calero Muñoz , N. Parellada Esquius , Y. Rando Matos","doi":"10.1016/j.semerg.2025.102642","DOIUrl":"10.1016/j.semerg.2025.102642","url":null,"abstract":"<div><h3>Objective</h3><div>To describe the therapy used for <em>Helicobacter pylori</em> (HP) infection and obtain the eradication rate in primary care (PC).</div></div><div><h3>Material and methods</h3><div>Descriptive cross-sectional observational study conducted at the Florida Primary Care Centre in L’Hospitalet de Llobregat (Barcelona). The study population consisted of patients aged 15 years or older with HP infection, and the variables were: active ingredients prescribed and their regimen, evaluation of eradication 28 days after diagnosis, sex, age, and country of origin.</div></div><div><h3>Results</h3><div>In 2018-2019-2020, 1,023 cases of HP were diagnosed, 65.4% (669) were women, mean age 47.17 years (SD 15.7; range 15-93), 56.9% of Spanish origin and 28.3% from Latin America. Quadruple therapy without bismuth with omeprazole 20 mg (OCAM20) was prescribed in 27.4% of the total, classic triple therapy with omeprazole 20 mg (OCA20) in 15%, and quadruple therapy with a single three-in-one capsule containing metronidazole, tetracycline, and bismuth (MTB) with omeprazole in 14.3%. In 15.9% of cases, no treatment was recorded, and in 9.3% of cases, an incorrect regimen was found. Verification tests were performed in 614 cases. It was found that OCA20 achieved an eradication rate of 82.3%, OCA with 40 mg/12 hours achieved 89.8%, OCAM20 achieved 88.0% and MTB achieved 84.7%, with no statistically significant differences between regimens (p=0.674).</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 9","pages":"Article 102642"},"PeriodicalIF":0.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145508081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Obesidad y sarcopenia: una asociación de alto impacto [肥胖和肌肉减少症：高影响关联]。

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-12-01 Epub Date: 2025-11-11 DOI: 10.1016/j.semerg.2025.102626

J. Santianes Patiño, C. Menéndez Fernández

引用次数: 0

Enfermedad hepática esteatótica, un enfoque holístico y preventivo desde la atención primaria 静压性肝病：从初级保健开始的整体预防方法

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-12-01 Epub Date: 2025-11-27 DOI: 10.1016/j.semerg.2025.102646

E. Peramato Martin

引用次数: 0

Afectación lingual como síntoma debut de arteritis de células gigantes [舌症状是巨细胞动脉炎的最初表现]。

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-12-01 Epub Date: 2025-11-10 DOI: 10.1016/j.semerg.2025.102619

M.I. Regal-Faraldo , E. Rodríguez Barros

引用次数: 0

Eritema pigmentado fijo ampolloso generalizado secundario a hidroferol. Un reto diagnóstico en medicina familiar y comunitaria 继发于氢铁醇的广泛性大疱性固定色素红斑。家庭和社区医学中的诊断挑战[j]。

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-12-01 Epub Date: 2025-11-10 DOI: 10.1016/j.semerg.2025.102623

V. Garrigasait Vilaseca , K. Valdivia Cortés , M.A. Jiménez Marrugo

引用次数: 0

Dermatitis lineal por Pyemotes ventricosus: una causa emergente de prurito agudo con signo de la cometa [脑室脓门引起的线状皮炎：彗星征急性瘙痒的新病因]。

IF 0.9 Q4 PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

Pub Date : 2025-12-01 Epub Date: 2025-11-05 DOI: 10.1016/j.semerg.2025.102613

D. Gallego-García, D. Robles-Murcia, R. Ruiz-Villaverde

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Medicina de Familia-SEMERGEN

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀